15
Views
87
CrossRef citations to date
0
Altmetric
Cell Growth and Development

The Mdm2 Oncoprotein Interacts with the Cell Fate Regulator Numb

, , , , &
Pages 3974-3982 | Received 17 Dec 1997, Accepted 21 Apr 1998, Published online: 28 Mar 2023
 

ABSTRACT

The Mdm2 oncoprotein is a well-known inhibitor of the p53 tumor suppressor, but it may also possess p53-independent activities. In search of such p53-independent activities, the yeast two-hybrid screen was employed to identify Mdm2-binding proteins. We report that in vitro and in transfected cells, Mdm2 can associate with Numb, a protein involved in the determination of cell fate. This association causes translocation of overexpressed Numb into the nucleus and leads to a reduction in overall cellular Numb levels. Through its interaction with Numb, Mdm2 may influence processes such as differentiation and survival. This could potentially contribute to the altered properties of tumor cells which overexpress Mdm2.

ACKNOWLEDGMENTS

We thank P. Wieder-Salamon and S. Wilder for excellent technical assistance. We thank S. Elledge for plasmids and cDNA library, E. Canaani and members of the Canaani lab for cDNA library and helpful suggestions, and A. Bershadsky and Y. Shay for helpful advice.

This research was supported in part by PHS grant RO1 CA 40099 from the National Cancer Institute and by the Leo and Julia Forchheimer Center for Molecular Genetics.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.